Emulate at MPS World Summit 2024
Connect with us and enter for a chance to win a week-long trip to Emulate HQ for Organ-Chip bootcamp!
Punch your ticket to win a trip to Emulate HQ!
Enter for a chance to take part in a week-long Organ-Chip bootcamp at Emulate HQ in Boston, MA by participating in at least four of our activities during MPS World Summit 2024. Stop by Booth #6 and pick up a Chip Ticket to start your entry! Show any Emulate employee proof of your activity to get your ticket punched. All completed tickets must be received by June 13th at 6:00 pm.
Qualifying Activities
- Attend our poster presentation (#313, June 13th, 4:30-6:00pm)
- Complete the survey in our booth
- Attend a hands-on training in the Emulate Lab (see below for details)
- Guess the number of chips in the bowl (winner gets an Emulate swag bag!)​
- Take a picture with Emulate in our booth, post it to LinkedIn, and tag us​
- Take a picture with your Chip Ticket in front of a Seattle landmark, share to LinkedIn, and tag us!
Emulate Lab
Stop by the Emulate Lab in Booth #6 for a hands-on demo of the Organ-Chip workflow from start to finish! General demonstrations can be given at any time, or see our schedule below for application-specific sessions!
Tuesday, June 11th
Cell & Gene Therapy | 10:15am & 11:00am
- Using the Liver-Chip to down-select for LNP-mediated toxicity
- Creating solid tumor models for CAR T efficacy studies
Modeling Physiological Barriers | 4:45pm & 5:30pm
- Combining organoids & Organ-Chips to model the intestine
Wednesday, June 12th
Cancer | 10:15am & 11:00am
- Recreating the tumor microenvironment with Chip-A1
Immunology | 4:45pm & 5:30pm
- Modeling the entire process of immune cell recruitment on chip
Thursday, June 13th
Infectious Disease & Vaccine Development | 10:15am & 11:00am
- Creating Organ-Chip models of lymph node and vagina
Skin Applications | 4:45pm & 5:30pm
- Using Chip-A1 to create skin models
Thursday, June 13th, 4:30 - 6:00 pm
Evaluating the Hepatotoxicity of Cannabidiol, Cannabinol, Cannabichromene and Cannabigerol Using a Human Quad-Culture Liver-Chip (#313)
James Velez1, Jacob Larson2, Sushma Jadalannagari1, Jake Chaff1, Josiah Sliz1, Lorna Ewart1, Donna Webster2, Jiang Hu2, Ben Swenor1
1 Emulate, Boston, USA. 2 Herbalife, Torrance, USA
Abstract
As the popularity of hemp-derived products grows, understanding the prospective hepatotoxicity of cannabinoids becomes crucial for personal safety. Despite conflicting evidence from limited human clinical studies, a safety gap persists, and no standard threshold has been established for these various cannabinoid-containing products. Furthermore, the hepatotoxicity potential of other cannabinoids like Cannabinol (CBN), Cannabichromene (CBC), and Cannabigerol (CBG) remains largely unexplored. The current study was designed to address some of these gaps by utilizing microphysiological systems (MPS), such as the Emulate Quad-Culture Liver-Chip, which adhere to IQMPS consortia guidelines, as an alternative to animal testing.